• John Paulson’s fund initiates Amicus Therapeutics position, dumps SOLS among Q1 moves MSN Sat, 23 May 2026 13:44:43 GMT
• Amicus Therapeutics stock (US03152W1099): analysts see limited upside after strong run AD HOC NEWS Thu, 21 May 2026 13:49:28 GMT
• Are Amicus Therapeutics (FOLD) and Autoliv (ALV) Overlooked Opportunities Kavout Thu, 21 May 2026 02:22:28 GMT
• john paulson’s fund initiates amicus therapeutics position, dumps sols among q1 moves MSN Wed, 20 May 2026 05:06:34 GMT
• john paulson’s fund initiates amicus therapeutics position, dumps sols among q1 moves MSN Mon, 18 May 2026 14:52:27 GMT
• john paulson’s fund initiates amicus therapeutics position, dumps sols among q1 moves MSN Sun, 17 May 2026 10:09:00 GMT
• paulson & co. acquires amicus therapeutics (fold) and exits solstice advanced materials (sols) GuruFocus Sat, 16 May 2026 09:43:56 GMT
• john paulson’s fund initiates amicus therapeutics position, dumps sols among q1 moves MSN Sat, 16 May 2026 08:42:45 GMT
• paulson & co. acquires amicus therapeutics (fold) and exits solstice advanced materials (sols) GuruFocus Fri, 15 May 2026 22:44:12 GMT
• layoff tracker: takeda cuts 4,500, novartis lays off biomedical research staff BioSpace Fri, 15 May 2026 07:00:00 GMT
• barclays holds 17.8m amicus shares (nasdaq: fold), 5.65% stake Stock Titan Fri, 15 May 2026 01:30:56 GMT
• amicus therapeutics stock (us03152w1099): biotech focused on rare diseases AD HOC NEWS Thu, 14 May 2026 16:12:57 GMT
• Barclays holds 17.8M Amicus shares (NASDAQ: FOLD), 5.65% stake Stock Titan Thu, 14 May 2026 07:00:00 GMT
• Abeona pivots to T cells; AstraZeneca’s rare disease drug passes Phase 3 Endpoints News Wed, 13 May 2026 15:36:00 GMT
• fold sec filings - amicus therapeut 10-k, 10-q, 8-k forms Stock Titan Tue, 12 May 2026 12:12:45 GMT
• BioMarin consolidates staff at Amicus HQ after closing $4.8B deal for rare disease peer Fierce Pharma Tue, 12 May 2026 07:00:00 GMT
• fold sec filings - amicus therapeut 10-k, 10-q, 8-k forms Stock Titan Mon, 11 May 2026 20:08:47 GMT
• Goldman Sachs (FOLD) discloses 16.78M shares, 5.3% ownership (Schedule 13G) Stock Titan Mon, 11 May 2026 07:00:00 GMT
• fabry disease treatment market to reach usd 3,530.5 million openPR.com Mon, 11 May 2026 06:44:51 GMT
• fold sec filings - amicus therapeut 10-k, 10-q, 8-k forms Stock Titan Fri, 08 May 2026 14:16:08 GMT
• UBS Group-affiliated funds hold 17.14M shares in Amicus Therapeutics (NASDAQ: FOLD) Stock Titan Thu, 07 May 2026 07:00:00 GMT
• which is a better investment, anaptysbio, inc. or amicus therapeutics, inc. stock? AAII.com Thu, 07 May 2026 04:05:41 GMT
• BioMarin: 'Strong Buy' On VOXZOGO Expansion And Amicus Acquisition (NASDAQ:BMRN) Seeking Alpha Wed, 06 May 2026 07:00:00 GMT
• biomarin enters 'transition year' as enzyme portfolio expands after amicus deal, morgan stanley says 富途牛牛 Tue, 05 May 2026 17:31:22 GMT
• biomarin to buy rare disease drugmaker amicus therapeutics for $4.8b MSN Tue, 05 May 2026 12:08:18 GMT
• biomarin beats estimates, raises guidance on amicus deal Investing.com Mon, 04 May 2026 20:27:00 GMT
• biomarin reports first quarter 2026 financial and operating results Santa Maria Times Mon, 04 May 2026 20:05:00 GMT
• ubs group ag grows position in amicus therapeutics, inc. $fold MarketBeat Mon, 04 May 2026 07:00:00 GMT
• cm management llc has $5.27 million stock position in amicus therapeutics, inc. $fold MarketBeat Sun, 03 May 2026 07:00:00 GMT
• biomarin amicus deal expands rare disease reach and adds kidney asset Sahm Fri, 01 May 2026 21:16:43 GMT
• Glazer Capital (FOLD) reports zero holdings after falling below 5% stake Stock Titan Fri, 01 May 2026 07:00:00 GMT
• pictet asset management holding sa trims stake in amicus therapeutics, inc. $fold MarketBeat Fri, 01 May 2026 07:00:00 GMT
• universal beteiligungs und servicegesellschaft mbh decreases holdings in amicus therapeutics, inc. $fold MarketBeat Fri, 01 May 2026 07:00:00 GMT
• biomarin to buy rare-disease biotech amicus therapeutics for $4.8 billion MSN Fri, 01 May 2026 04:11:02 GMT
• biomarin amicus deal expands rare disease reach and adds kidney asset simplywall.st Thu, 30 Apr 2026 15:15:20 GMT
• amicus therapeutics (fold) expected to announce earnings on thursday MarketBeat Thu, 30 Apr 2026 07:00:00 GMT
• amicus therapeutics, inc. financial disclosures & filings TradingView Thu, 30 Apr 2026 06:06:42 GMT
• Vanguard Capital Management holds 5.20% of Amicus Therapeutics (NASDAQ: FOLD) Stock Titan Wed, 29 Apr 2026 07:00:00 GMT
• BioMarin Closes Amicus Deal As FOLD Delists And Indices Adjust simplywall.st Wed, 29 Apr 2026 07:00:00 GMT
• amicus therapeutics, inc.(nasdaqgm: fold) dropped from s&p global bmi index marketscreener.com Wed, 29 Apr 2026 01:21:24 GMT
• amicus therapeutics, inc.(nasdaqgm:fold) dropped from s&p biotechnology select industry index marketscreener.com Wed, 29 Apr 2026 01:21:04 GMT
• net current asset value per share of amicus therapeutics, inc. – biva:fold TradingView Tue, 28 Apr 2026 14:37:35 GMT
• BioMarin acquires Amicus Therapeutics for $4.8bn Pharmaceutical Technology Tue, 28 Apr 2026 07:00:00 GMT
• BioMarin closes $4.8bn Amicus deal to expand rare disease portfolio MSN Tue, 28 Apr 2026 07:00:00 GMT
• BioMarin closes $4.8B Amicus deal to boost rare disease portfolio MSN Tue, 28 Apr 2026 07:00:00 GMT
• amicus therapeutics, inc.(nasdaqgm:fold) dropped from s&p biotechnology select industry index marketscreener.com Tue, 28 Apr 2026 07:00:00 GMT
• amicus therapeutics, inc.(nasdaqgm: fold) dropped from s&p tmi index marketscreener.com Tue, 28 Apr 2026 07:00:00 GMT
• biomarin to buy rare-disease biotech amicus therapeutics for $4.8 billion MSN Tue, 28 Apr 2026 02:09:50 GMT
• amicus therapeutics, inc.(nasdaqgm: fold) dropped from russell 3000 index marketscreener.com Mon, 27 Apr 2026 22:00:00 GMT
• biomarin to buy rare-disease biotech amicus therapeutics for $4.8 billion MSN Mon, 27 Apr 2026 13:57:39 GMT
• biomarin completes amicus acquisition, expands rare disease portfolio TipRanks Mon, 27 Apr 2026 13:21:35 GMT
• cibra capital makes a big merger arbitrage bet on amicus therapeutics (fold) AOL.com Mon, 27 Apr 2026 10:35:44 GMT
• Amicus Therapeutics Announced Transfer or Voluntary Withdrawal of Listing TradingView Mon, 27 Apr 2026 07:00:00 GMT
• BioMarin Completes $4.8 Billion Acquisition of Amicus Therapeutics citybiz Mon, 27 Apr 2026 07:00:00 GMT
• Amicus Therapeutics Repays and Terminates 2023 Blackstone Credit Agreement Following Merger TradingView Mon, 27 Apr 2026 07:00:00 GMT
• Amicus Therapeutics withdraws Nasdaq listing | FOLD SEC Filing - Form 25-NSE Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• Amicus Therapeutics (NASDAQ: FOLD) taken private in $14.50-per-share cash merger Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• Amicus Therapeutics (NASDAQ: FOLD) director’s shares and options cashed out in BioMarin deal Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• Amicus Therapeutics (FOLD) director cashes out stock and options in BioMarin deal Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• BioMarin (NASDAQ: BMRN) adds Galafold and Pombiliti in Amicus deal Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• Amicus Therapeutics (NASDAQ: FOLD) director cashes out equity in BioMarin deal Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• Amicus Therapeutics (FOLD) CPO equity fully cashed out at $14.50 deal price Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• BioMarin deal pays Amicus (NASDAQ: FOLD) director $14.50 per share Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• Amicus Therapeutics (FOLD) CEO disposes 1.0M shares, options in BioMarin merger Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• Amicus (FOLD) chief legal officer exits equity as BioMarin buyout pays $14.50 Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• BioMarin-Amicus deal pays out Amicus (NASDAQ: FOLD) director Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• BioMarin acquisition cashes out Amicus (FOLD) director’s shares and options Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• BioMarin Pharmaceutical Closes $4.8 Billion Acquisition of Amicus Therapeutics Moomoo Mon, 27 Apr 2026 07:00:00 GMT
• BioMarin-Amicus deal pays CDO Castelli (FOLD) $14.50 per share Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• BioMarin completes $4.8B acquisition of Amicus Therapeutics By Investing.com Investing.com Canada Mon, 27 Apr 2026 07:00:00 GMT
• amicus therapeutics (nasdaq: fold) director equity paid out at $14.50 in biomarin deal Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• director at amicus (nasdaq: fold) exits stake in biomarin deal Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• amicus therapeutics (fold) cao exits stock and options in biomarin deal Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• amicus therapeutics, inc.(nasdaqgm:fold) dropped from russell small cap completeness index marketscreener.com Mon, 27 Apr 2026 07:00:00 GMT
• amicus therapeutics (fold) cfo exits equity as biomarin acquisition closes Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• amicus therapeutics, inc.(nasdaqgm: fold) dropped from nasdaq composite index marketscreener.com Sun, 26 Apr 2026 22:00:00 GMT
• biomarin to buy rare-disease biotech amicus therapeutics for $4.8 billion MSN Sun, 26 Apr 2026 17:30:58 GMT
• CIBRA Capital Increases Amicus Therapeutics Holdings – April 2026 SEC Filing - News and Statistics IndexBox Sun, 26 Apr 2026 07:00:00 GMT
• cibra capital ltd increases amicus therapeutics stake by $21 million HarianBasis.co Sat, 25 Apr 2026 16:06:28 GMT
• CIBRA Capital Makes a Big Merger Arbitrage Bet On Amicus Therapeutics (FOLD) The Motley Fool Sat, 25 Apr 2026 07:00:00 GMT
• Assessing Amicus Therapeutics (FOLD) Valuation After Recent Share Price Momentum And Rare Disease Growth Prospects simplywall.st Fri, 24 Apr 2026 07:00:00 GMT
• fold stock price, quote & chart | amicus therapeutics inc (nasdaq:fold) ChartMill Fri, 24 Apr 2026 07:00:00 GMT
• fold price today: amicus therapeutics, inc. stock price, quote & chart | mexc MEXC Exchange Fri, 24 Apr 2026 07:00:00 GMT
• amicus therapeutics stock hits 52-week high at $14.48 by investing.com Investing.com Australia Fri, 24 Apr 2026 05:11:18 GMT
• according to the latest public documents from the u.s. securities and exchange commission (sec), the french regulatory authority o... Bitget Thu, 23 Apr 2026 20:58:01 GMT
• amicus gains final approval for biomarin acquisition completion TipRanks Thu, 23 Apr 2026 20:44:49 GMT
• fold (amicus therapeutics inc.) posts steep q4 2025 eps miss, shares edge up slightly in daily trading. - trending stock ideas Cổng thông tin điện tử tỉnh Lào Cai Thu, 23 Apr 2026 09:13:45 GMT
• california biotech biomarin will pay $4.8 billion for amicus therapeutics, a rare-disease company with a presence in philadelphia MSN Thu, 23 Apr 2026 08:37:36 GMT
• French approval clears way for Amicus (NASDAQ: FOLD) merger with BioMarin Stock Titan Thu, 23 Apr 2026 07:00:00 GMT
• amicus therapeutics (nasdaq:fold) sets new 12-month high - time to buy? MarketBeat Thu, 23 Apr 2026 07:00:00 GMT
• biomarin (bmrn) wins french fdi clearance ahead of amicus merger close Stock Titan Thu, 23 Apr 2026 07:00:00 GMT
• amicus receives french fdi clearance, merger with biomarin set to close april 27, 2026 TradingView Thu, 23 Apr 2026 07:00:00 GMT
• biomarin receives french clearance for amicus merger, closing expected soon Investing.com Thu, 23 Apr 2026 07:00:00 GMT
• fold (amicus therapeutics inc.) posts steep q4 2025 eps miss, shares edge up slightly in daily trading. - trending social stocks Cổng thông tin điện tử tỉnh Tây Ninh Wed, 22 Apr 2026 23:42:01 GMT
• how amicus therapeutics inc. (fold) affects rotational strategy timing Stock Traders Daily Tue, 21 Apr 2026 03:48:01 GMT
• why is amicus therapeutics (fold) stock moving (unchanged) 2026-04-20 - social trading insights Cổng thông tin điện tử tỉnh Tây Ninh Mon, 20 Apr 2026 14:55:32 GMT
• amicus therapeutics, inc. experiences revision in stock evaluation amid strong market performance Markets Mojo Sun, 19 Apr 2026 20:34:53 GMT
• amicus therapeutics (nasdaq:fold) share price crosses above 200 day moving average - here's what happened MarketBeat Sat, 18 Apr 2026 07:00:00 GMT
• massachusetts financial services co. ma has $1.79 million position in amicus therapeutics, inc. $fold MarketBeat Sat, 18 Apr 2026 07:00:00 GMT
• amicus therapeutics experiences revision in stock evaluation amid mixed performance indicators Markets Mojo Sat, 18 Apr 2026 05:02:14 GMT
• amicus therapeutics, inc. experiences revision in stock evaluation amid strong market performance Markets Mojo Wed, 15 Apr 2026 16:05:33 GMT
• biomarin pharmaceutical's rare disease portfolio supplemented by amicus acquisition makes it a buy Seeking Alpha Wed, 15 Apr 2026 07:00:00 GMT
• biomarin to buy rare-disease biotech amicus therapeutics for $4.8 billion MSN Wed, 15 Apr 2026 04:38:33 GMT
• amicus therapeutics announces full-year 2025 financial results and corporate updates ADVFN Sun, 12 Apr 2026 08:49:13 GMT
• how does amicus therapeutics inc score in quality rankings - 2026 biggest moves & community shared stock ideas baoquankhu1.vn Sat, 11 Apr 2026 07:34:10 GMT
• patterns watch: will amicus therapeutics inc benefit from geopolitical trends - portfolio gains summary & consistent growth equity... baoquankhu1.vn Sat, 11 Apr 2026 01:49:30 GMT
• amicus therapeutics, inc. (nasdaq:fold) given consensus rating of "hold" by brokerages MarketBeat Fri, 10 Apr 2026 07:00:00 GMT
• (fold) and the role of price-sensitive allocations Stock Traders Daily Fri, 10 Apr 2026 02:38:01 GMT
• fabry disease market set for robust growth by 2034, driven by gene therapy breakthroughs and expanding pipeline from sangamo, sano... Barchart.com Thu, 09 Apr 2026 18:36:07 GMT
• gap down: will amicus therapeutics inc benefit from geopolitical trends - buy signal & reliable momentum entry alerts baoquankhu1.vn Thu, 09 Apr 2026 03:07:11 GMT
• amicus therapeutics stock hits 52-week high at 14.46 usd by investing.com Investing.com Australia Wed, 08 Apr 2026 07:00:00 GMT
• fold financials: revenue breakdown, margins & competitor comparison Intellectia AI Tue, 07 Apr 2026 17:26:36 GMT
• biomarin pharmaceutical secures european regulatory approval for amicus therapeutics acquisition marketscreener.com Tue, 07 Apr 2026 11:08:10 GMT
• Amicus Therapeutics stock hits 52-week high at 14.46 USD Investing.com Tue, 07 Apr 2026 07:00:00 GMT
• amicus therapeutics (nasdaq:fold) hits new 1-year high - time to buy? MarketBeat Tue, 07 Apr 2026 07:00:00 GMT
• eu commission oks biomarin's sole acquisition of amicus therapeutics marketscreener.com Tue, 07 Apr 2026 07:00:00 GMT
• capricorn fund managers ltd invests $3 million in amicus therapeutics, inc. $fold MarketBeat Mon, 06 Apr 2026 07:00:00 GMT
• amicus therapeutics stock hits 52-week high at $14.44 by investing.com Investing.com South Africa Wed, 01 Apr 2026 06:57:27 GMT
• biomarin to buy rare-disease biotech amicus therapeutics for $4.8 billion msn.com Tue, 31 Mar 2026 16:14:09 GMT
• amicus therapeutics (nasdaq:fold) reaches new 1-year high - still a buy? MarketBeat Mon, 30 Mar 2026 07:00:00 GMT
• Assessing Amicus Therapeutics (FOLD) Valuation After A Strong 71% One Year Total Return Yahoo Finance Sun, 29 Mar 2026 07:00:00 GMT
• 210,800 shares in amicus therapeutics, inc. $fold acquired by cibra capital ltd MarketBeat Sun, 29 Mar 2026 07:00:00 GMT
• An Open Letter to the Pompe and Fabry Communities | BioMarin BioMarin Pharmaceutical Fri, 27 Mar 2026 07:00:00 GMT
Amicus Therapeutics, Inc(NASDAQ:FOLD) 
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for people living with rare metabolic diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed dia...
Website: http://www.amicusrx.com
Founded: 2002
Full Time Employees: 584
Sector: Healthcare
Industry: Biotechnology